Femoston (Estradiol, Dydrogesterone). Product Summary

FEMOSTON^®

FEMOSTON^®
(Estradiol & Dydrogesterone)

Indications for 1/10 mg:

Sequential combined is indicated for Oestrogen deficiency in postmenopausal women 6 months or more after last menstruation
Indications for 1/5 mg:
Indicated for oestrogen deficiency symptoms in postmenopausal women 12 months or more after last menstruation

Available Dosage:

28 Tablets 1/5 mg
28 Tablets 1/10 mg

MAKING AN EVERLASTING IMPACT ON HUMAN HEALTH FOR 125 YEARS.

KEEPING YOU HEALTHY
PRODUCTS
ABOUT ABBOTT

SITE MAP
CONTACT
PRIVACY POLICY
TERMS OF USE

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAKING AN EVERLASTING IMPACT ON HUMAN HEALTH FOR 125 YEARS.

link01

link01

© 2022 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

ARE YOU A HEALTHCARE PROFESSIONAL?